CrushSCI.com
Journal Selection & Manuscript Polishing Services
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE journal cover Medicine
Back to journal directory

Review Cycle Records

MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE

Springer SCIE Non-OA
2026 Emerging Zone 42025 CAS Zone 42025 JCR Q2
159.9Average days
160.5Median days
112Fastest days
232Longest days
962025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

112 days

The potential of advanced MR techniques for precision radiotherapy of glioblastoma

AuthorsPatrick L. Y. Tang; Alejandra Méndez Romero; Jaap P. M. Jaspers; Esther A. H. Warnert

Affiliations1. Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands; 2. Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands

Source PDF DOI Publisher page
162 days

What do we know about dynamic glucose-enhanced (DGE) MRI and how close is it to the clinics? Horizon 2020 GLINT consortium report

AuthorsMina Kim; Afroditi Eleftheriou; Luca Ravotto; Bruno Weber; Michal Rivlin; Gil Navon; Martina Capozza; Annasofia Anemone; Dario Livio Longo; Silvio Aime; Moritz Zaiss; Kai Herz; Anagha Deshmane; Tobias Lindig; Benjamin Bender; Xavier Golay

Affiliations1. Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK; 2. Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK; 3. Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland; 4. Neuroscience Center Zurich, Zurich, Switzerland; 5. School of Chemistry, Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel; 6. Molecular Imaging Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy; 7. Institute of Biostructures and Bioimaging (IBB), National Research Council of Italy (CNR), Torino, Italy; 8. Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, Tübingen, Germany; 9. Neuroradiology, University Clinic Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; 10. Department of Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany; 11. Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Tübingen, Germany

Source PDF DOI Publisher page
176 days

3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T

AuthorsYulun Wu; Tobias C. Wood; Fatemeh Arzanforoosh; Juan A. Hernandez-Tamames; Gareth J. Barker; Marion Smits; Esther A. H. Warnert

Affiliations1. Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands; 2. Brain Tumor Centre, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; 3. Centre for Neuroimaging Science, King’s College London, London, UK

Source PDF DOI Publisher page
165 days

Diagnostic performance of edited 2HG MR spectroscopy of central glioma in the clinical environment

AuthorsDominik Juskanič; Jana Poláková Mištinová; Samuel Hollý; Monika Sekerešová; Kamil Koleják; Lukáš Pátrovič

Affiliations1. JESSENIUS-Diagnostic Center, Nitra, Slovakia; 2. Medical Faculty, Comenius University in Bratislava, Bratislava, Slovakia; 3. Faculty Hospital, Nitra, Slovakia

Source PDF DOI Publisher page
164 days

Evaluation of normal-appearing white matter with perfusion and diffusion MRI in patients with treated glioblastoma

AuthorsSinan Şahin; Ersen Ertekin; Tuna Şahin; Yelda Özsunar

Affiliations1. Department of Radiology, Adnan Menderes University, Aydın, Turkey

Source PDF DOI Publisher page
135 days

A systematic review on the use of quantitative imaging to detect cancer therapy adverse effects in normal-appearing brain tissue

AuthorsJan Petr; Louise Hogeboom; Pavel Nikulin; Evita Wiegers; Gwen Schroyen; Jesper Kallehauge; Marek Chmelík; Patricia Clement; Ruben E. Nechifor; Liviu-Andrei Fodor; Philip C. De Witt Hamer; Frederik Barkhof; Cyril Pernet; Maarten Lequin; Sabine Deprez; Radim Jančálek; Henk J. M. M. Mutsaerts; Francesca B. Pizzini; Kyrre E. Emblem; Vera C. Keil

Affiliations1. Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany; 2. Department of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam, The Netherlands; 3. Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands; 4. Department of Imaging and Pathology, KU Leuven, Leuven, Belgium; 5. Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark; 6. Department of Technical Disciplines in Medicine, Faculty of Health Care, University of Prešov, Prešov, Slovakia; 7. Ghent Institute for Functional and Metabolic Imaging (GIfMI), Ghent University, Ghent, Belgium; 8. International Institute for the Advanced Studies of Psychotherapy and Applied Mental Health, Department of Clinical Psychology and Psychotherapy, Babeș-Bolyai University, Cluj-Napoca, Romania; 9. International Institute for the Advanced Studies of Psychotherapy and Applied Mental Health, Evidence Based Psychological Assessment and Interventions Doctoral School, Babeș-Bolyai University, Cluj-Napoca, Romania; 10. Department of Neurosurgery, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam, The Netherlands; 11. UCL Queen Square Institute of Neurology, University College London, London, UK; 12. Neurobiology Research Unit, Copenhagen University Hospital, Rigshospitalet, Denmark; 13. St. Anne’s University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic; 14. Radiology, Deptartment of Diagnostic and Public Health, Verona University, Verona, Italy; 15. Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway

Source PDF DOI Publisher page
159 days

Feasibility of intravoxel incoherent motion in the assessment of tumor microvasculature and blood–brain barrier integrity: a case-based evaluation of gliomas

AuthorsAndre Monteiro Paschoal; Maria Clara Zanon Zotin; Lucas Murilo da Costa; Antonio Carlos dos Santos; Renata Ferranti Leoni

Affiliations1. LIM44, Instituto e Departamento de Radiologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil; 2. Medical School of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil; 3. InBrain Lab, FFCLRP, University of Sao Paulo, Ribeirao Preto, Brazil; 4. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA

Source PDF DOI Publisher page
151 days

GLINT: GlucoCEST in neoplastic tumors at 3 T—clinical results of GlucoCEST in gliomas

AuthorsBenjamin Bender; Kai Herz; Anagha Deshmane; Vivien Richter; Ghazaleh Tabatabai; Jens Schittenhelm; Marco Skardelly; Klaus Scheffler; Ulrike Ernemann; Mina Kim; Xavier Golay; Moritz Zaiss; Tobias Lindig

Affiliations1. Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Tübingen, Germany; 2. Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany; 3. Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, Tübingen, Germany; 4. Department of Biomedical Magnetic Resonance, University Hospital Tübingen, Tübingen, Germany; 5. Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Tübingen, Germany; 6. Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany; 7. Cluster of Excellence iFIT (EXC 2180) “Image Guided and Functionally Instructed Tumor Therapies”, Eberhard Karls University Tübingen, Tübingen, Germany; 8. German Consortium for Translational Cancer Research (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Tübingen, Germany; 9. Department of Neuropathology, University Hospital Tübingen, Tübingen, Germany; 10. Department of Neurosurgery, University Hospital Tübingen, Tübingen, Germany; 11. Department of Neurosurgery, Klinikum am Steinenberg, Reutlingen, Germany; 12. Institute of Neurology, University College London, London, UK; 13. Department of Neuroradiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany

Source PDF DOI Publisher page
232 days

Detection of glioblastoma multiforme using quantitative molecular magnetic resonance imaging based on 5-aminolevulinic acid: in vitro and in vivo studies

AuthorsAnita Ebrahimpour; Fatemeh Tirgar; Behnam Hajipour-Verdom; Ardeshir Abbasi; Mahmoudreza Hadjighassem; Parviz Abdolmaleki; Saereh Hosseindoost; Seyed Amir Hossein Javadi; Hassan Hashemi; Abbas Rahimi Foroushani; Nader Riyahi Alam; Mehdi Khoobi

Affiliations1. Department of Medical Physics and Biomedical Engineering, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran; 2. Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran; 3. Department of Biophysics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran; 4. Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran; 5. Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran; 6. Department of Neurosurgery, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran; 7. Department of Radiology, Faculty of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran; 8. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; 9. Concordia University, PERFORM Center, Montreal, Canada; 10. Biomaterials Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran; 11. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Source PDF DOI Publisher page
143 days

Feasibility of glioblastoma tissue response mapping with physiologic BOLD imaging using precise oxygen and carbon dioxide challenge

AuthorsVittorio Stumpo; Martina Sebök; Christiaan Hendrik Bas van Niftrik; Katharina Seystahl; Nicolin Hainc; Zsolt Kulcsar; Michael Weller; Luca Regli; Jorn Fierstra

Affiliations1. Department of Neurosurgery, University Hospital Zurich, Zurich, Switzerland; 2. Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland; 3. Department of Neurology, University Hospital Zurich, Zurich, Switzerland; 4. Department of Neuroradiology, University Hospital Zurich, Zurich, Switzerland

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.